A model of the unfolded protein response: Pancreatic β-cell as a case study

Cellular Physiology and Biochemistry

Volumn 23, Issue 4-6, 2009, Pages 233-244

  Schnell, Santiago ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus; Enzyme kinetics; Insulin production; Mathematical model; Protein homeostasis

Indexed keywords

APOPTOSIS; ARTICLE; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; MATHEMATICAL MODEL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS;

EID: 66749130213     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218170     Document Type: Article

References (71)

1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P: Molecular biology of the cell, ed 4th edition. New York, Garland Science 2002.
2. Rutkowski DT, Kaufman RJ: A trip to the ER: Coping with stress. Trends Cell Biol 2004;14:20-28.
3. Ghaemmaghami S, Huh W, Bower K, Howson RW, Belle A, Dephoure N, O'Shea EK, Weissman JS: Global analysis of protein expression in yeast. Nature 2003;425:737-741.
4. Kim PS, Arvan P: Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 1998;19:173-202.
5. Schroder M, Kaufman RJ: ER stress and the unfolded protein response. Mutat Res-Fundam Mol Mech Mutagen 2005;569:29-63.
6. Ron D, Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529.
7. Xu CY, Bailly-Maitre B, Reed JC: Endoplasmic reticulum stress: Cell life and death decisions. J Clin Invest 2005;115:2656-2664.
8. Brostrom CO, Brostrom MA: Regulation of translational initiation during cellular responses to stress. Prog Nucleic Acid Res Mol Biol 1998;58:79-125.
9. Harding HP, Novoa I, Bertolotti A, Zeng H, Zhang Y, Urano F, Jousse C, Ron D: Translational regulation in the cellular response to biosynthetic load on the endoplasmic reticulum. Cold Spring Harbor Symp Quant Biol 2001;66:499-508.
10. Sekijima Y, Wiseman RL, Matteson J, Hammarstrom P, Miller SR, Sawkar AR, Balch WE, Kelly JW: The biological and chemical basis for tissue-selective amyloid disease. Cell 2005;121:73-85.
11. Lee AS: Mammalian stress response: Induction of the glucose-regulated protein family. Current Opinion in Cell Biology 1992;4:267-273.
12. Ma YJ, Hendershot LM: ER chaperone functions during normal and stress conditions. J Chem Neuroanat 2004;28:51-65.
13. Brodsky JL: The protective and destructive roles played by molecular chaperones during ERAD (endoplasmicreticulum-associated degradation). Biochem J 2007;404:353-363.
14. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P: Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 2000;101:249-258.
15. Anelli T, Sitia R: Protein quality control in the early secretory pathway. Embo J 2008;27:315-327.
16. Liu M, Hodish I, Rhodes CJ, Arvan P: Proinsulin maturation, misfolding, and proteotoxicity. Proceedings of the National Academy of Sciences 2007;104:15841-15846.
17. Schuit FC, Tveld PAI, Pipeleers DG: Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pacreatic beta-cells. Proc Natl Acad Sci U S A 1988;85:3865-3869.
18. Schuit FC, Kiekens R, Pipeleers DG: Measuring the balance between insulin synthesis and insulin release. Biochem Biophys Res Commun 1991;178:1182-1187.
19. Van Lommel L, Janssens K, Quintens R, Tsukamoto K, Vander Mierde D, Lemaire K, Denef C, Jonas JC, Martens G, Pipeleers D, Schuit FC: Probeindependent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes 2006;55:3214-3220.
20. Scheuner D, Kaufman RJ: The unfolded protein response: A pathway that links insulin demand with β-cell failure and diabetes. Endocr Rev 2008;29:317-333.
21. Allotey RA, Mohan V, McDermott MF, Deepa R, Premalatha G, Hassan Z, Cassell P G, North B V, Vaxillaire M, Mein CA, Swan DC, O'Grady E, Ramachandran A, Snehalatha C, Sinnot P, Hemmatpour SK, Froguel P, Hitman GA: The EIF2AK3 gene region and type 1 diabetes in subjects from South India. Genes and Immunity 2004;5:648-652.
22. Meex SJR, van Greevenbroek MMJ, Ayoubi TA, Vlietinck R, van Vliet-Ostaptchouk JV, Hofker MH, Vermeulen V, Schalkwijk CG, Feskens EJM, Boer JMA, Stehouwer CDA, van der Kallen CJH, de Bruin TWA: Activating transcription factor 6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians. Journal of Clinical Endocrinology and Metabolism 2007;92:2720-2725.
23. Thameem F, Farook VS, Bogardus C, Prochazka M: Association of amino acid variants in the activating transcription factor 6 gene (ATF6) on 1q21-q23 with type 2 diabetes in Pima Indians. Diabetes 2006;55:839-842.
24. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the Chop gene delays endoplasmic reticulum stressmediated diabetes. J Clin Invest 2002;109:525-532.
25. C95S mutant mice. Diabetes 2007;56:1268-1276.
26. Støy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, Below JE, Hayes MG, Cox NJ, Lipkind GM, Lipton RB, Greeley SAW, Patch A-M, Ellard S, Steiner DF, Hattersley AT, Philipson LH, Bell GI: Insulin gene mutations as a cause of permanent neonatal diabetes. Proceedings of the National Academy of Sciences 2007;104:15040-15044.
27. Guo Z Y, Feng YM: Effects of cysteine to serine substitutions in the two interchain disulfide bonds of insulin. Biol Chem 2001;382:443-448.
28. Yoshioka M, Kayo T, Ikeda T, Koizumi A: A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57Bl/ 6 (Akita) mutant mice. Diabetes 1997;46:887-894.
29. Wang J, Takeuchi T, Tanaka S, Kubo SK, Kayo T, Lu D, Takata K, Koizumi A, Izumi T: A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the mody mouse. J Clin Invest 1999;103:27-37.
30. Kayo T, Koizumi A: Mapping of murine diabetogenic gene mody on chromosome 7 at D7Mit258 and its involvement in pancreatic islet and β cell development during the perinatal period. J Clin Invest 1998;101:2112-2118.
31. Ron D: Proteotoxicity in the endoplasmic reticulum: Lessons from the Akita diabetic mouse. J Clin Invest 2002;109:443-445.
32. +/Akita pancreatic β cells. Genes Cells 2004;9:261-270.
33. Allen JR, Nguyen LX, Sargent KE, Lipson KL, Hackett A, Urano F: High ER stress in β-cells stimulates intracellular degradation of misfolded insulin. Biochem Biophys Res Commun 2004;324:166-170.
34. Gilchrist A, Au CE, Hiding J, Bell AW, Fernandez-Rodriguez J, Lesimple S, Nagaya H, Roy L, Gosline SJC, Hallett M, Paiement J, Kearney Robert E, Nilsson T, Bergeron JJM: Quantitative proteomics analysis of the secretory pathway. Cell 2006;127:1265-1281.
35. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK: Physicochemical modelling of cell signalling pathways. Nat Cell Biol 2006;8:1195-1203.
36. Kholodenko BN: Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 2006;7:165-176.
37. Kitano H: Systems biology: A brief overview. Science 2002;295:1662-1664.
38. Schnell S, Grima R, Maini PK: Multiscale modeling in biology. Am Scientist 2007;95:134-142.
39. Wiseman RL, Powers ET, Buxbaum JN, Kelly JW, Balch WE: An adaptable standard for protein export from the endoplasmic reticulum. Cell 2007;131:809-821.
40. Loo TW, Clarke DM: Chemical and pharmacological chaperones as new therapeutic agents. Expert Rev Mol Med 2007;9:1-18.
41. Aridor M: Visiting the ER: The endoplasmic reticulum as a target for therapeutics in traffic related diseases. Adv Drug Deliv Rev 2007;59:759-781.
42. Kohno K: How transmembrane proteins sense endoplasmic reticulum stress. Antioxid Redox Signal 2007;9:2295-2303.
43. Bertolotti A, Zhang YH, Hendershot LM, Harding HP, Ron D: Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2000;2:326-332.
44. Harding HP, Zhang YH, Ron D: Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999;397:271-274.
45. Harding HP, Zhang YH, Bertolotti A, Zeng HQ, Ron D: Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000;5:897-904.
46. Schroder M, Kaufman RJ: The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-789.
47. Haze K, Yoshida H, Yanagi H, Yura T, Mori K: Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 1999;10:3787-3799.
48. Yarnamoto K, Sato T, Matsui T, Sato M, Okada T, Yoshida H, Harada A, Mori K: Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6 α and XBP1. Dev Cell 2007;13:365-376.
49. Wu J, Rutkowski DT, Dubois M, Swathirajan J, Saunders T, Wang J, Song B, Yau GDY, Kaufman RJ: ATF6 α optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev Cell 2007;13:351-364.
50. Bukau B, Weissman J, Horwich A: Molecular chaperones and protein quality control. Cell 2006;125:443-451.
51. Helenius A, Aebi M: Roles of n-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 2004;73:1019-1049.
52. Young JC, Agashe VR, Siegers K, Hartl FU: Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 2004;5:781-791.
53. Zhang KZ, Kaufman RJ: From endoplasmic-reticulum stress to the inflammatory response. Nature 2008;454:455-462.
54. Nölting B: Protein folding kinetics: Biophysical methods, Second edition. Berlin, Springer, 2006.
55. Hoffmann F, Posten C, Rinas U: Kinetic model of in vivo folding and inclusion body formation in recombinant Escherichia coli. Biotechnol Bioeng 2001;72:315-322.
56. Hasegawa K, Ono K, Yamada M, Naiki H: Kinetic modeling and determination of reaction constants of Alzheimer's β-amyloid fibril extension and dissociation using surface plasmon resonance. Biochemistry 2002;41:13489-13498.
57. Murphy RM, Tsai AM: Protein folding, misfolding, stability and aggregation; in Murphy RM, Tsai AM (eds): Misbehaving proteins: Protein (mis)folding, aggregation, and stability. New York, Springer, 2006, vol 1
58. Fersht A: Structure and mechanism in protein science: A guide to enzyme catalysis and protein folding. New York, W. H. Freeman and Company, 1999.
59. Segel IW: Enzyme kinetics. Behavior and analysis of rapid-equilibrium and steadystate enzyme systems. John Wiley & Sons, Inc., 1975.
60. Schnell S, Mendoza C: Time-dependent closed form solutions for fully competitive enzyme reactions. Bulletin of Mathematical Biology 2000;62:321-336.
61. Schreiber G: Kinetic studies of proteinprotein interactions. Current Opinion in Structural Biology 2002;12:41-47.
62. Roberts CJ: Non-native protein aggregation kinetics. Biotechnology and Bioengineering 2007;98:927-938.
63. Haynes CM, Titus EA, Cooper AA: Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell 2004;15:767-776.
64. Shimizu Y, Hendershot LM: Organization of the functions and components of the endoplasmic reticulum; in Csermely P and Vígh L (eds): Molecular aspects of the stress response: Chaperones, membranes and networks. Berlin, Springer-Verlag Berlin, 2007, vol 594, pp 37-46.
65. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Gorgun CZ, Hotamisligil GS: Chemical chaperones reduce er stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006;313:1137-1140.
66. Kincaid MM, Cooper AA: Eradicate ER stress or die trying. Antioxid Redox Signal 2007;9:2373-2387.
67. Anderson MS, Bluestone JA: The NOD mouse: A model of immune dysregulation. Annu Rev Immunol 2005;23:447-485.
68. Rieger TR, Morimoto RI, Hatzimanikatis V: Bistability explains threshold phenomena in protein aggregation both in vitro and in vivo. Biophys J 2006;90:886-895.
69. Gonzalez R, Andrews BA, Asenjo JA: Kinetic model of BiP- and PDI-mediated protein folding and assembly. J Theor Biol 2002;214:529-537.
70. Robinson AS, Lauffenburger DA: Model for ER chaperone dynamics and secretory protein interactions. Aiche J 1996;42:1443-1453.
71. Landersdorfer CB, Jusko WJ: Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus. Clinical Pharmacokinetics 2008;47:417-448.